Moretti August J

CIK 00013444124 companiesMOUNTAIN VIEW, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001344412

Recent Transactions

50 trades

Award
Cibus, Inc.$CBUS
Stock Option (Right-to-Buy)
2025-05-22+39,301→ 39,301 total
Award
Cibus, Inc.$CBUS
Stock Option (Right-to-Buy)
2024-11-20+14,733→ 14,733 total
Exercise/Conversion
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2023-05-15$9.41/sh+3,000→ 11,045 total
Exercise/Conversion
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2023-05-15−3,000→ 217,060 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2023-02-10+50,000→ 50,000 total
Exercise/Conversion
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2022-12-21−3,000→ 220,060 total
Exercise/Conversion
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2022-12-21$9.41/sh+3,000→ 6,595 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2022-09-01−60,000→ 60,000 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2022-02-01−65,000→ 65,000 total
Exercise/Conversion
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2021-04-12−1,000→ 223,060 total
Exercise/Conversion
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2021-04-12$9.41/sh+1,000→ 2,000 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2021-03-08+70,000→ 70,000 total
Tax Payment
Assertio Therapeutics, Inc
Common stock
2018-03-31$6.59/sh−6,975→ 74,447 total
Disposition to Issuer
Assertio Therapeutics, Inc
Stock Options
2017-12-18+92,500→ 0 total
Disposition to Issuer
Assertio Therapeutics, Inc
Stock Options
2017-12-18+55,000→ 0 total
Disposition to Issuer
Assertio Therapeutics, Inc
Stock Options
2017-12-18+54,200→ 0 total
Tax Payment
Assertio Therapeutics, Inc
Common stock
2017-12-01$7.11/sh−10,336→ 58,949 total
Tax Payment
Assertio Therapeutics, Inc
Common stock
2017-04-02$12.55/sh−940→ 41,785 total
Award
Assertio Therapeutics, Inc
Restricted Stock Units
2017-03-31+40,000→ 40,000 total
Award
Assertio Therapeutics, Inc
Stock Options
2017-02-08+54,200→ 54,200 total
Award
Assertio Therapeutics, Inc
Restricted Stock Units
2017-02-08+23,000→ 23,000 total
Tax Payment
Assertio Therapeutics, Inc
Common stock
2016-12-01$18.55/sh−10,853→ 40,225 total
Exercise/Conversion
Assertio Therapeutics, Inc
Common Stock
2016-11-14−5,000→ 48,741 total
Sale
Assertio Therapeutics, Inc
Common Stock
2016-11-14$20.84/sh−5,000→ 21,680 total
Exercise/Conversion
Assertio Therapeutics, Inc
Common Stock
2016-11-14$12.69/sh+5,000→ 26,680 total
Sale
Assertio Therapeutics, Inc
Common Stock
2016-08-10$21.40/sh−3,297→ 21,680 total
Exercise/Conversion
Assertio Therapeutics, Inc
Common Stock
2016-08-10−3,297→ 53,741 total
Sale
Assertio Therapeutics, Inc
Common stock
2016-08-10$21.40/sh−1,703→ 21,680 total
Exercise/Conversion
Assertio Therapeutics, Inc
Common Stock
2016-08-10$12.69/sh+3,297→ 24,977 total
Sale
Assertio Therapeutics, Inc
Common stock
2016-05-09$18.00/sh−5,000→ 22,879 total
Tax Payment
Assertio Therapeutics, Inc
Common stock
2016-04-02$14.38/sh−940→ 27,879 total
Award
Assertio Therapeutics, Inc
Stock Options
2016-02-11+92,500→ 92,500 total
Award
Assertio Therapeutics, Inc
Restricted Stock Units
2016-02-11+37,500→ 37,500 total
Exercise/Conversion
Assertio Therapeutics, Inc
Stock Option
2015-12-16−5,000→ 192,500 total
Exercise/Conversion
Assertio Therapeutics, Inc
Common Stock
2015-12-16$5.35/sh+5,000→ 26,319 total
Sale
Assertio Therapeutics, Inc
Common Stock
2015-12-03$18.12/sh−13,159→ 23,160 total
Sale
Assertio Therapeutics, Inc
Common Stock
2015-12-03$18.01/sh−1,841→ 21,319 total
Tax Payment
Assertio Therapeutics, Inc
Common stock
2015-12-01$19.00/sh−7,329→ 36,319 total
Award
Assertio Therapeutics, Inc
Restricted Stock Units
2015-05-12+5,000→ 5,000 total
Award
Assertio Therapeutics, Inc
Restricted Stock Units
2015-02-04+22,000→ 22,000 total
Award
Assertio Therapeutics, Inc
Stock Options
2015-02-04+55,000→ 55,000 total
Sale
Assertio Therapeutics, Inc
Common Stock
2014-12-02$15.85/sh−5,339→ 22,564 total
Award
Assertio Therapeutics, Inc
Restricted Stock Unit
2014-02-18+27,500→ 27,500 total
Award
Assertio Therapeutics, Inc
Stock Option
2014-02-18+65,000→ 65,000 total
Sale
Assertio Therapeutics, Inc
Common Stock
2013-12-02$8.40/sh−2,821→ 11,214 total
Exercise/Conversion
Assertio Therapeutics, Inc
Common Stock
2013-05-17$5.35/sh+2,500→ 3,752 total
Exercise/Conversion
Assertio Therapeutics, Inc
Stock Option
2013-05-17−2,500→ 197,500 total
Award
Assertio Therapeutics, Inc
Stock Option
2013-02-07+53,500→ 53,500 total
Award
Assertio Therapeutics, Inc
Restricted Stock Unit
2013-02-07+28,500→ 28,500 total
Award
Assertio Therapeutics, Inc
Stock Option
2012-01-03+200,000→ 200,000 total

Companies

Recent Filings

Address

ALEXZA PHARMACEUTICALS INC. 2091 STIERLIN COURT

MOUNTAIN VIEW, CA, 94043

View on SEC.gov